Platform Technology Partners
- SEC CIK
- 0001830817
- Latest filing
- Jul 24, 2026
PHAS holding history
PhaseBio Pharmaceuticals Inc in every 13F filed by Platform Technology Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PHAS overviewAll 13F holders of PHASFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −231,900−100.0% | Sold out | Holders |
| Q3 2022 | 231,900 | $41.0K | <0.1% | −11,000−4.5% | Reduced | Holders |
| Q2 2022 | 242,900 | $146.0K | 0.1% | +427+0.2% | Added | Holders |
| Q1 2022 | 242,473 | $320.0K | 0.2% | −9,250−3.7% | Reduced | Holders |
| Q4 2021 | 251,723 | $657.0K | 0.3% | +22,500+9.8% | Added | Holders |
| Q3 2021 | 229,223 | $713.0K | 0.3% | −150−0.1% | Reduced | Holders |
| Q2 2021 | 229,373 | $853.0K | 0.4% | – | No prior filing | Holders |